Tag: Pharma
TME PHARMA – Financing guarantee agreement as part of the launch of a capital increase of €2.2 million intended for professional investors and individuals in France via Primarybid – 06/17/2024 at 6:48 p.m.
TME PHARMA ANNOUNCES A FINANCING GUARANTEE AGREEMENT AS PART OF THE LAUNCH OF A CAPITAL INCREASE OF MINIMUM 2.2 MILLION EUROS FOR TO PROFESSIONAL INVESTORS AND INDIVIDUALS IN FRANCE VIA…
Innate Pharma: clinical benefit for a phase 1/2 trial in leukemia – 06/17/2024 at 10:08 a.m.
(AOF) – Innate Pharma shared new results from the phase 1/2 trial led by Sanofi evaluating NK cell engage SAR443579/IPH6101 in various blood cancers. It “continues to show clinical benefit,…
Innate pharma: Positive phase 1/2 data in leukemia
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
ABIONYX Pharma successfully passed the pre-IND meeting with the FDA for a phase 2b/3 clinical study evaluating CER-001 in the treatment of patients with sepsis – 06/13/2024 at 7:30 p.m.
• Based on promising data from its Phase 2a study and a successful meeting with the Food and Drug Administration (FDA), ABIONYX Pharma will file an IND application in the…
Pharma: Genoway doubled its net profit in 2023
(AOF) – genOway announces having achieved consolidated turnover of 20 million euros in 2023, organic growth of 18% compared to 2022. This company specializes in the design, development and marketing…
Pharma: Genoway doubled its net profit in 2023 – 06/05/2024 at 6:09 p.m.
(AOF) – genOway announces having achieved consolidated turnover of 20 million euros in 2023, organic growth of 18% compared to 2022. This company specializes in the design, development and marketing…
Innate Pharma: positive data in mycosis fungoides – 06/04/2024 at 09:23
(CercleFinance.com) – Innate Pharma announces positive results from the phase II TELLOMAK study evaluating its lacutamab in mycosis fungoides, during the annual meeting of the American Society of Clinical Oncology…
Innate Pharma: positive results for lacutamab – 06/04/2024 at 09:36
(AOF) – Innate Pharma today announced positive results from the Tellomak Phase 2 study evaluating lacutamab in mycosis fungoides, presented at the annual meeting of the American Society of Clinical…
Medesis Pharma: new financing, visibility until October 20245 – 06/04/2024 at 10:11
(AOF) – Medesis Pharma announces today that it has obtained financing and entered into an agreement with its clinical research organization (CRO) for the analysis of the results of the…
MaaT Pharma: Karim Dabbagh is reappointed as President
By Alexandra Saintpierre Published on 05/29/2024 at 8:49 p.m. Photo credit © Maat Pharma (Boursier.com) — MaaT…
Innate pharma: Five abstracts selected for ASCO
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Innate Pharma: five abstracts selected for ASCO
(CercleFinance.com) – Innate Pharma announces that five abstracts concerning its drug candidates have been selected for the annual congress of ASCO (American Society of Clinical Oncology), which will be held…